Re:A cancer trial’s unexpected result: Remission in every pa...
by elhudy on Sunday June 05, 2022 @09:42PM
(#31636573)
BTK inhibitors are technically in 3rd gen (noncovalent) already if you can get in the trials (which are very promising considering they use the same mechanism).
https://www.lls.org/treatment/types-treatment/immunotherapy/...
Also 2nd gen BTK inhibitors:
https://en.wikipedia.org/wiki/Acalabrutinib
https://en.wikipedia.org/wiki/Bruton%27s_tyrosine_kinase